dm+d

Unassigned

New Medicines

Complicated urinary tract infection - IV formulation

Information

New molecular entity
Iterum Therapeutics
Iterum Therapeutics

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Penem antibiotic active against resistant enterobacteriaceae
In England (2018/19), ~190,000 hospital admissions were for complicated urinary tract infections, including pyelonephritis and sepsis due to gram-negative bacteria. [10]
Complicated urinary tract infection - IV formulation
Intravenous